Ri/Nova gene-associated paraneoplastic subacute motor neuronopathy

Muscle and Nerve

Volumn 47, Issue 4, 2013, Pages 617-618

  Younger, David S ^a   Graber, Jerome ^b   Hayakawa Yano, Yoshika ^c   Parveen, Salina ^c   Frank, Mayu ^c   Darnell, Robert B ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUORODEOXYGLUCOSE; FLUOROURACIL; IMMUNOGLOBULIN; METHOTREXATE; NOVA PROTEIN; ONCOPROTEIN; PACLITAXEL; RIBONUCLEASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIBODY TITER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CEREBROSPINAL FLUID; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FATIGUE; GENETIC ASSOCIATION; HUMAN; LETTER; MOTOR NEUROPATHY; MUSCLE CRAMP; MUSCLE TWITCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; POSITRON; PRIORITY JOURNAL; SPINAL CORD;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; MOTOR NEURON DISEASE; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RNA-BINDING PROTEINS;

EID: 84875634694     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23783     Document Type: Letter

References (16)

1. Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK, Jr. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve 2012;46:823-827.
2. Schold SC, Cho ES, Somasundaram M, Posner JB. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol 1979;5:271-287.
3. Budde-Steffen C, Anderson NE, Rosenblum MK, Graus F, Ford D, Synek BJ, et al. An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 1988;23:528-531.
4. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003;53:580-587.
5. Henson RA, Russell DS, Wilkinson M. Carcinomatous neuropathy and myopathy a clinical and pathological study. Brain 1954;77:82-121.
6. Walton JN, Tomlinson BE, Pearce GW. Subacute "poliomyelitis" and Hodgkin's disease. J Neurol Sci 1968;6:435-445.
7. Rowland LP, Schneck SA. Neuromuscular disorders associated with malignant neoplastic disease. J Chron Dis 1963;16:777-795.
8. Bauer M, Bergstrom R, Ritter B, Olsson Y. Macroglobulinemia Waldenstrom and motor neuron syndrome. Acta Neurol Scand 1977;55:245-250.
9. Younger DS, Rowland LP, Latov N, Hays AP, Lange DJ, Sherman W, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 1991;29:78-86.
10. Nagao M, Nakamura M, Oka N, Akiguchi I, Kimura J. Abnormal glycosylation of motor neurons with N-acetyl-D-galactosamine in a case of subacute motor neuronopathy associated with lymphoma. J Neurol 1994;241:372-375.
11. Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, et al. Lymphoproliferative disorders and motor neuron disease: an update. Neurology 1997;48:1671-1678.
12. Stoll DB, Lublin F, Brodovsky H, Laucius JF, Patchefsky A, Cooper H. Association of subacute motor neuronopathy with thymoma. Cancer 1984;54:770-772.
13. Evans BK, Fagan C, Arnold T, Dropcho EJ, Oh SJ. Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology 1990;40:960-962.
14. Graus F, Rowe G, Fueyo J, Darnell RB, Dalmau J. The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons. Neurosci Lett 1993;150:212-214.
15. Buckanovich RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 1993;11:657-672.
16. Yang YY, Yin GL, Darnell RB. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A 1998;95:13254-13259.